NCT05064527 is a clinical trial of wearable biosensor in Obsessive-Compulsive Disorder, sponsored by Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital.

Who is sponsoring NCT05064527?

NCT05064527 is sponsored by Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital.

What drugs are being tested in NCT05064527?

Interventions in NCT05064527: wearable biosensor, Treatment as usual (TAU), Exposure and response prevention (ERP).

What condition does NCT05064527 study?

NCT05064527 studies Obsessive-Compulsive Disorder.

Is NCT05064527 still recruiting?

NCT05064527 is currently completed. Last updated 3 February 2023.

Last reviewed 2023-02-03 · How we verify

NCT05064527

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Wearable AI Feedback Tool for Pediatric OCD

Completed Last updated 3 February 2023

What this trial tests

trial testing wearable biosensor in Obsessive-Compulsive Disorder in 36 participants. Completed in 19 January 2023.

Timeline

15 September 2021

Primary endpoint
19 January 2023

19 January 2023

Quick facts

Lead sponsor	Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	36
Start date	15 September 2021
Primary completion	19 January 2023
Estimated completion	19 January 2023
Sites	1 location across Denmark

Drugs / interventions tested

wearable biosensor
Treatment as usual (TAU) — full drug profile →
Exposure and response prevention (ERP)

Conditions studied

Obsessive-Compulsive Disorder — all drugs for Obsessive-Compulsive Disorder →

Sponsor

Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital

Who can join

Adults 8 to 17, any sex, with Obsessive-Compulsive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To test the feasibility of implementing digitally enhanced psychotherapy and research in a community child and adolescent mental health center including the acceptability of the digital technology to patients, parents and therapists. To use passively collected physiological data and actively collected clinical and biochemical data from the patient and parents to detect and predict episodes of obsessive-compulsive disorder (OCD) -related episodes in children and accommodating behaviour in parents.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Predicting obsessive-compulsive disorder episodes in adolescents using a wearable biosensor-A wrist angel feasibility study.
Lønfeldt NN, Olesen KV, Das S, Mora-Jensen AC, et al · · 2023 · cited 7× · PMID 37850105 · DOI 10.3389/fpsyt.2023.1231024
A Wearable Artificial Intelligence Feedback Tool (Wrist Angel) for Treatment and Research of Obsessive Compulsive Disorder: Protocol for a Nonrandomized Pilot Study.
Lønfeldt NN, Clemmensen LKH, Pagsberg AK. · · 2023 · cited 5× · PMID 37486738 · DOI 10.2196/45123
Predicting Obsessive-Compulsive Disorder Events in Children and Adolescents in the Wild using a Wearable Biosensor (Wrist Angel): Protocol for the Analysis Plan of a Nonrandomized Pilot Study.
Olesen KV, Lønfeldt NN, Das S, Pagsberg AK, et al · · 2023 · cited 3× · PMID 37962931 · DOI 10.2196/48571

Verify or expand the search:

Other recruiting trials for Obsessive-Compulsive Disorder

Currently open trials in the same condition.

NCT06575075 — Pilot Study of RR-HNK in OCD · Phase 1, PHASE2 · recruiting
NCT05783817 — MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study) · Phase 2 · recruiting
NCT07065669 — Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation · NA · recruiting
NCT06376734 — Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness · Phase 2 · recruiting
NCT07000812 — EEG Evaluation of CBT for Obsessive-Compulsive Disorder · NA · active not recruiting

Other Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital trials

Trials by the same sponsor.

NCT07404085 — Epigenetic Enhancement of Cognitive Training in Aging Mood Disorder Populations · NA · recruiting
NCT07302165 — PreParent: Internet-based Digital Tools to Screen for and Prevent Postpartum Depression in Parents-to-be · NA · enrolling by invitation
NCT06919133 — The Effect of Digital Markers in the Self-management of Depressive Symptoms · NA · enrolling by invitation
NCT06755710 — Patient Engagement in PTSD Treatment (PEP) · NA · recruiting
NCT06993831 — ENGAGE: Virtual Reality-based Psychotherapy for Negative Symptoms in Schizophrenia · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05064527 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Last refreshed: 3 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05064527.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing